| ID | Name | CAS | Data |
MW (g/mol) |
| 123-631-4 |
Formosanan-16-carboxylic acid, 19-methyl-2-oxo-, methyl ester, (19«alpha»)-
|
509-80-8 |
3 | 368.43 |
| 123-653-0 |
2,4-Pregnadien-(2,3-d)isoxazol-17.alpha.-ethynyl-17.beta.-ol, TMS
|
|
3 | 409.65 |
| 123-686-4 |
3,5-Dihydroxybenzoic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
3 | 496.90 |
| 123-817-8 |
5,5-Diethyl-2-methyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 198.27 |
| 123-964-5 |
6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-one, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,8aS)-
|
510-77-0 |
3 | 285.34 |
| 123-994-2 |
1,3,2-Diazaphosphol-4-ene, 2-ethyl-1,3-dibutyl-4,5-dimethyl-
|
106054-01-7 |
3 | 256.37 |
| 124-022-9 |
5-«alpha»-Pregnan-3-«beta»,21-diol-20-one, MeTMS
|
|
3 | 478.86 |
| 124-026-5 |
2-Butenoic acid, 2-methyl-,8-methyl-6-(1-oxopropoxy)-8-azabicyclo[3.2.1]oct-3-yl ester, [1R-[1«alpha»,3«beta»(E),5«alpha»,6«alpha»]]-
|
54354-59-5 |
3 | 295.37 |
| 124-148-0 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,6-dimethyl-7-phenyl
|
|
3 | 242.28 |
| 124-159-8 |
3,4-Dihydroxybenzoic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
3 | 496.90 |
| 124-238-0 |
N-(6-Methoxy-1,3-benzothiazol-2-yl)-2,2,3,3,3-pentafluoropropanamide
|
|
3 | 326.24 |
| 124-267-8 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-methyl-phosphorothioamidate
|
|
3 | 253.64 |
| 124-269-6 |
D-Pipecolic acid, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
3 | 271.35 |
| 124-293-9 |
Nicotinic acid, 1,2-dihydro-4,6-dimethyl-5-nitro-2-oxo-, ethyl ester
|
6972-37-8 |
3 | 240.21 |
| 124-317-2 |
Cyclopentane-1,2-dione, 3,3,5,5-tetramethyl, bis(o-methyloxime)-(E,Z)-
|
140210-45-3 |
3 | 212.29 |
| 124-350-5 |
2-Chloro-10-(3'-dimethylaminopropyl)phenothiazine, 5-oxide, hydrochloride, monohydrate
|
|
3 | 389.34 |
| 124-391-0 |
2,6-Piperidinedione, 1-[(octahydro-2H-quinolizin-1-yl)methyl]-, (1R-cis)-
|
18688-40-9 |
3 | 264.36 |
| 124-453-1 |
1,3,2-Diazaphosphol-4-ene, 2-ethoxy-1,3-dibutyl-4,5-dimethyl-
|
|
3 | 272.37 |
| 124-523-3 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, hexyl ester
|
|
3 | 387.39 |
| 124-527-9 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, decyl ester
|
|
3 | 443.50 |
| 124-533-2 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, butyl ester
|
|
3 | 359.34 |
| 124-571-0 |
5-Methyl-9-azabicyclo[3.3.1]nonan-3-one, N-trifluoroacetyl
|
|
3 | 249.23 |
| 124-612-4 |
Pentan-2-one, 4-methyl-4-ethoxyamino, O-ethyloxime, syn
|
|
3 | 202.30 |
| 124-628-7 |
2-Nonenoic acid, 4-hydroxy, TMS, methyl ester, # 2
|
|
3 | 258.43 |
| 124-634-0 |
Pyrrolidin-2-one, 1-[1-(4-carbomethoxyphenyl)butan-1-ol-2-yl]-
|
|
3 | 291.34 |
| 124-641-2 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-isobutyl-phosphorothioamidate
|
|
3 | 281.69 |
| 124-647-6 |
Pregn-5-en-20-one, 3,16-bis[(trimethylsilyl)oxy]-, O-methyloxime, (3«beta»,16«alpha»)-
|
57305-31-4 |
3 | 505.88 |
| 124-670-0 |
2-Hydroxy-5-methoxybenzoic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
3 | 396.68 |
| 124-671-9 |
R,S-4'-Methoxy-«alpha»-pyrrolidinopropiophenone-M (desmethyl-3HO-), 2ET
|
|
3 | 291.39 |
| 124-692-6 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N,N-dimethyl-phosphorothioamidate
|
|
3 | 267.66 |
| 124-747-5 |
Benzenepropanoic acid, 3-methoxy-«alpha»,4-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
55887-61-1 |
3 | 428.74 |
| 124-791-6 |
20.alpha.-hydroxy-pregn-4-en-3-one, MO-TMS, anti
|
|
3 | 417.71 |
| 124-793-4 |
6H-Pyrido[2,1-b]quinazolin-6-one, 7,8,9,10-tetrahydro-8-methyl
|
|
3 | 214.26 |
| 124-859-1 |
(E)-Methyl 2-((1'R,6'R,7'S,8a'S)-6'-ethyl-2-oxo-3',5',6',7',8',8a'-hexahydro-2'H-spiro[indoline-3,1'-indolizin]-7'-yl)-3-methoxyacrylate
|
76-66-4 |
3 | 384.47 |
| 124-895-1 |
11H-Pyrido[2,1-b]quinazolin-11-one, 1,2,3,4,6,7,8,9-octahydro, 9-methyl
|
|
3 | 218.30 |
| 124-968-0 |
Galanthan-1-ol, 3,12-didehydro-9,10-[methylenebis(oxy)]-, (1«alpha»)-
|
477-12-3 |
3 | 271.31 |
| 125-109-2 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, dodecyl ester
|
|
3 | 485.58 |
| 125-279-4 |
N,N-Dimethyl-N'-(3-methyl-2,6-dioxotetrahydro-2H-pyran-3-yl)imidoformamide
|
|
3 | 198.22 |
| 10-068-5 |
3«alpha»,6«alpha»,7«beta»,12«alpha»-Tetrahydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
2 | 727.32 |
| 10-210-6 |
2,2,4,6,8,10-hexamethyl-4,6,8,10-tetra(2-cyanoethyl)-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 526.91 |
| 10-421-2 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3,20-O)-diTBDMSi
|
|
2 | 565.03 |
| 10-423-0 |
5-«alpha»-Androst-1-ene-3-«beta»,17-«beta»-diol, TMS
|
|
2 | 434.80 |
| 10-453-7 |
5-[(1E)-3,3-dimethyl-1-triazenyl]-1h-imidazole-4-carbohydrazide
|
116401-55-9 |
2 | 197.20 |
| 10-569-9 |
6-Azido-5-tert-butyldiphenylsilyloxy-2,3,6-trideoxy-D-threo-hexofuranose
|
|
2 | 285.41 |
| 10-635-5 |
2,2,4,4,6,8,8,10,12-nonamethyl-8,10,12-tri(2-cyanoethyl)-[1,3,5,7,9,11,2,4,6,8,10,12]cyclohexasiloxane
|
|
2 | 562.04 |
| 10-945-1 |
Formamide, n-benzyl-n-[3-benzyl-6-benzylamino-4-thioxo-5-pyrimidinyl]-
|
|
2 | 440.57 |
| 10-950-5 |
DL-3-Aminoisobutyric acid, N-(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 331.65 |
| 10-960-4 |
5«beta»-Androst-1-en-6«beta»-ol-3,17-dione,tris-TMS
|
|
2 | 518.95 |
| 11-040-4 |
6-Methyl, 2-methylmercapto-4-oxo-1,3,3a,7-tetrazaindene
|
|
2 | 196.24 |
| 11-047-7 |
ent-6-«alpha»,7-«alpha»,12-«alpha»-Trihydroxykaurenonic acid, methyl ester, TMS
|
|
2 | 581.02 |
| 11-078-3 |
Silane, (1,1-dimethylethyl)dimethyl[(6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-yl)oxy]-
|
61595-80-0 |
2 | 424.69 |
| 11-174-6 |
Silane, diphenyl(2,2,3,4,4,4-hexafluorobutoxy)hexyloxy-
|
|
2 | 464.52 |
| 11-193-5 |
(9E,12Z)-Tetradeca-9,12-dien-1-ol, tert-tert-butyldimethylsilyl ether
|
|
2 | 324.62 |
| 11-283-5 |
4-(4-Diethylamino-2-methylphenylimino)-1-oxo-N-phenyl-1,4-dihydro-2-naphthalenecarboxamide
|
|
2 | 437.54 |
| 11-348-3 |
Glucaric acid, 2,3,4,5-tetrakis-O-(trimethylsilyl)-, bis(trimethylsilyl) ester
|
38165-96-7 |
2 | 643.23 |
| 11-368-1 |
6.beta.-Hydroxy-3.alpha., 5.alpha.-cycloandrostan-17-one, TMS
|
|
2 | 432.80 |
| 11-373-5 |
Pentanoic acid, 2-[(tert-butyldimethylsilyl)oxy]-, tert-butyldimethylsilyl ester, (DL)-
|
|
2 | 346.65 |
| 11-605-7 |
D-Ribo-Hexonic acid, 3-deoxy-2,5,6-tris-O-(trimethylsilyl)-, lactone
|
55570-78-0 |
2 | 378.68 |
| 11-774-0 |
5-«beta»-Pregnan-3-«beta»-ol-11-one, MO-TMS
|
|
2 | 419.72 |
| 11-797-5 |
Silane, [[(3«alpha»,5«beta»,20S)-pregnane-3,17,20-triyl]tris(oxy)]tris[trimethyl-
|
17846-09-2 |
2 | 553.05 |
| 11-872-1 |
5-«alpha»-Pregnan-11-«beta»,20-«alpha»-diol-3-one, MO-TMS
|
|
2 | 507.90 |
| 12-262-7 |
3-Acetyl-5-benzylmercapto-1,3,4-thiadiazolidone-2-azine
|
114383-24-3 |
2 | 528.69 |
| 12-325-7 |
Methyl 5-«beta»-cholan-3-«alpha»,7-«alpha»-diol-12-one-24-oate, oxime, TMS
|
|
2 | 652.14 |
| 12-353-6 |
3.beta.,6.alpha.-Dihydroxy-5.alpha.-androstan-17-one, TMS
|
|
2 | 522.99 |
| 12-370-7 |
(E)-10-Dodecenoic acid, 9-hydroxy-12-oxo, methyl ester, PFB-oxime, OH-TMS, # 2
|
|
2 | 509.58 |
| 12-398-7 |
5«beta»-Androst-1-en-17«beta»-methyl-3«alpha»,17«alpha»-diol, TMS
|
|
2 | 448.83 |
| 12-410-2 |
1-(2-Methoxyethoxy)-2-methyl-2-propanol, (3-cyanopropyl)dimethylsilyl ether
|
|
2 | 273.45 |
| 12-444-5 |
L-Aspartic acid, N-(tert-butyldimethylsilyl)-, bis(tert-butyldimethylsilyl) ester
|
107715-96-8 |
2 | 475.89 |
| 12-449-0 |
13,14-Dihydro-15-keto-PGF2A, BO-TMS, isomer # 2
|
|
2 | 642.15 |
| 12-473-3 |
4-Butyl-1-phenyl-pyrazolidine-3,5-diol, O,O'-bis(tert-butyldimethylsilyl) ether
|
|
2 | 460.81 |
| 12-499-5 |
2-tert-Butyldimethylsilyl-3-N,N-bis(tert-butyldimethylsilyl)amino-1,2,4-triazole
|
|
2 | 426.86 |
| 12-589-5 |
Androst-1,4-dien-17«alpha»-methyl-4-chloro-17«beta»-ol-3-one, TMS
|
|
2 | 479.24 |
| 12-592-1 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-6.«alpha»,17«beta»-diol, bisTMTBS
|
|
2 | 585.06 |
| 12-624-5 |
5«alpha»-Androstane-3«beta»,15«alpha»,17«beta»-triol, TMS
|
|
2 | 525.00 |
| 12-638-0 |
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 1,4-dihydro-
|
|
2 | 136.11 |
| 12-792-9 |
4-(2-[2-(2,4,6-Trichlorophenoxy)ethoxy]ethyl)morpholine
|
|
2 | 354.66 |
| 12-825-2 |
6-tert-Butyl-3-methylsulfanyl-5-trimethylsilyloxy-1,2,4-triazine
|
|
2 | 271.46 |
| 12-906-2 |
3-«beta»,7-«beta»-Dihydroxy-5-androsten-17-one, TMS
|
|
2 | 477.83 |
| 12-997-2 |
2,2,4,6,8,10-hexamethyl-4,6,8,10-tetraphenyl-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 619.05 |
| 13-028-6 |
3«alpha»,6«beta»,7«alpha»,12«alpha»-Tetrahydroxy-5«beta»-cholanoic acid, MeTMS
|
|
2 | 727.32 |
| 13-034-9 |
1,5-Diazobicyclo[3.2.1]octane, 8-indol-3-yl-
|
|
2 | 227.31 |
| 13-228-4 |
4,4'-Diacetyl-[2,2'-azo-1,3,4-thiadiazol-5-one]
|
116529-22-7 |
2 | 314.30 |
| 13-252-7 |
3-«beta»,6-«alpha»,7-«alpha»,12-«alpha»-Tetrahydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
2 | 727.32 |
| 13-321-0 |
1-(tert-Butyldimethylsilyl)-5-chloroindole-2-carboxylic acid, tert-butyldimethylsilyl ester
|
|
2 | 424.13 |
| 13-345-4 |
2-(2,2-Dimethylpentoxy)-3-methyl-6-(n-pentyl) pyrazine
|
116668-94-1 |
2 | 278.43 |
| 13-357-1 |
Propanoic acid, 2-[(4-aminocarbonylimidazol-5-yl)-1-triazen-1,3-diyl-], ethyl ester
|
|
2 | 254.25 |
| 13-376-0 |
[14C] GA7 di-acid 9,10-ene, methyl ester TMS ether
|
|
2 | 488.76 |
| 13-445-3 |
5«alpha»-Androstane-3«alpha»,6«beta»,17«beta»-triol, TMS
|
|
2 | 525.00 |
| 13-612-7 |
Acetamide, n-(6-chloro-5-nitro-4-oxo-3,4-dihydro-pyrimidin-2-yl)-
|
|
2 | 232.58 |
| 13-659-6 |
4-Nitro-N-(4-p-tolyl-thiazol-2-yl)-benzeneamine, N-tert.-butyldimethylsilyl-
|
|
2 | 425.62 |
| 13-715-3 |
6'-Glucosyl-gentobiose: aD-Glcp(1->6)-bDGlcp(1->6)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 1385.63 |
| 13-805-3 |
3«alpha»,16«alpha»-dihydroxy-5«beta»-androstan-17-one, MO-TMS, (syn,anti)
|
|
2 | 538.00 |
| 13-915-1 |
L-Histidine, N,1-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
107716-00-7 |
2 | 497.94 |
| 14-057-3 |
2,6-Diamino-4-oxo-1,3,3a,7-tetrazaindene mono-hydrochloride
|
|
2 | 166.14 |
| 14-085-2 |
5-«alpha»-Androst-9(11)-ene-3-«alpha»,17-«beta»-diol, TMS
|
|
2 | 434.80 |
| 14-103-1 |
N6-TFA-2'-Deoxyadenosine, 3'-O-TBDMS, 5'-O-TFA
|
|
2 | 557.52 |
| 14-386-8 |
Hexanedioic acid, 2-[(tert-butyldimethylsilyl)amino]-, bis(tert-butyldimethylsilyl) ester
|
|
2 | 503.94 |
| 14-467-8 |
3.beta.,19.alpha.-bis-(Trimethylsilyloxy)-20,29,30-trisnorlupane
|
|
2 | 547.03 |
| 14-471-3 |
1-Propene-1,2,3-tricarboxylic acid, tris(trimethylsilyl) ester, (E)-
|
55530-72-8 |
2 | 390.65 |
| 14-509-1 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-6.«alpha»,17«beta»-diol, bisTMS
|
|
2 | 448.83 |
|
« Previous Results
Next Results »
|